China · Delayed Price · Currency is CNY Boai NKY Medical Holdings Statistics
Total Valuation
SHE:300109 has a market cap or net worth of CNY 8.47 billion. The enterprise value is 8.10 billion.
| Market Cap | 8.47B |
| Enterprise Value | 8.10B |
Important Dates
The last earnings date was Friday, April 24, 2026.
| Earnings Date | Apr 24, 2026 |
| Ex-Dividend Date | Jul 10, 2025 |
Share Statistics
SHE:300109 has 483.38 million shares outstanding. The number of shares has increased by 2.30% in one year.
| Current Share Class | 483.38M |
| Shares Outstanding | 483.38M |
| Shares Change (YoY) | +2.30% |
| Shares Change (QoQ) | +4.15% |
| Owned by Insiders (%) | 17.82% |
| Owned by Institutions (%) | 4.29% |
| Float | 397.23M |
Valuation Ratios
The trailing PE ratio is 49.59.
| PE Ratio | 49.59 |
| Forward PE | n/a |
| PS Ratio | 7.09 |
| PB Ratio | 2.31 |
| P/TBV Ratio | 2.59 |
| P/FCF Ratio | 60.72 |
| P/OCF Ratio | 23.38 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.29, with an EV/FCF ratio of 58.05.
| EV / Earnings | 46.42 |
| EV / Sales | 6.77 |
| EV / EBITDA | 21.29 |
| EV / EBIT | 29.19 |
| EV / FCF | 58.05 |
Financial Position
The company has a current ratio of 3.21, with a Debt / Equity ratio of 0.09.
| Current Ratio | 3.21 |
| Quick Ratio | 2.38 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.86 |
| Debt / FCF | 2.36 |
| Interest Coverage | 35.67 |
Financial Efficiency
Return on equity (ROE) is 4.66% and return on invested capital (ROIC) is 6.55%.
| Return on Equity (ROE) | 4.66% |
| Return on Assets (ROA) | 3.93% |
| Return on Invested Capital (ROIC) | 6.55% |
| Return on Capital Employed (ROCE) | 7.17% |
| Weighted Average Cost of Capital (WACC) | 5.21% |
| Revenue Per Employee | 1.01M |
| Profits Per Employee | 147,062 |
| Employee Count | 1,186 |
| Asset Turnover | 0.27 |
| Inventory Turnover | 1.89 |
Taxes
In the past 12 months, SHE:300109 has paid 48.62 million in taxes.
| Income Tax | 48.62M |
| Effective Tax Rate | 22.11% |
Stock Price Statistics
The stock price has increased by +6.96% in the last 52 weeks. The beta is 0.20, so SHE:300109's price volatility has been lower than the market average.
| Beta (5Y) | 0.20 |
| 52-Week Price Change | +6.96% |
| 50-Day Moving Average | 18.46 |
| 200-Day Moving Average | 17.98 |
| Relative Strength Index (RSI) | 34.55 |
| Average Volume (20 Days) | 11,925,209 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300109 had revenue of CNY 1.20 billion and earned 174.42 million in profits. Earnings per share was 0.35.
| Revenue | 1.20B |
| Gross Profit | 544.73M |
| Operating Income | 277.34M |
| Pretax Income | 219.87M |
| Net Income | 174.42M |
| EBITDA | 378.97M |
| EBIT | 277.34M |
| Earnings Per Share (EPS) | 0.35 |
Balance Sheet
The company has 672.11 million in cash and 328.89 million in debt, with a net cash position of 343.22 million or 0.71 per share.
| Cash & Cash Equivalents | 672.11M |
| Total Debt | 328.89M |
| Net Cash | 343.22M |
| Net Cash Per Share | 0.71 |
| Equity (Book Value) | 3.67B |
| Book Value Per Share | 7.66 |
| Working Capital | 1.02B |
Cash Flow
In the last 12 months, operating cash flow was 362.23 million and capital expenditures -222.75 million, giving a free cash flow of 139.48 million.
| Operating Cash Flow | 362.23M |
| Capital Expenditures | -222.75M |
| Depreciation & Amortization | 101.62M |
| Net Borrowing | -164.27M |
| Free Cash Flow | 139.48M |
| FCF Per Share | 0.29 |
Margins
Gross margin is 45.57%, with operating and profit margins of 23.20% and 14.59%.
| Gross Margin | 45.57% |
| Operating Margin | 23.20% |
| Pretax Margin | 18.40% |
| Profit Margin | 14.59% |
| EBITDA Margin | 31.71% |
| EBIT Margin | 23.20% |
| FCF Margin | 11.67% |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 1.11%.
| Dividend Per Share | 0.20 |
| Dividend Yield | 1.11% |
| Dividend Growth (YoY) | -75.07% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 74.13% |
| Buyback Yield | -2.30% |
| Shareholder Yield | -1.19% |
| Earnings Yield | 2.06% |
| FCF Yield | 1.65% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 7, 2024. It was a forward split with a ratio of 1.5.
| Last Split Date | Jun 7, 2024 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
SHE:300109 has an Altman Z-Score of 8.84 and a Piotroski F-Score of 6.
| Altman Z-Score | 8.84 |
| Piotroski F-Score | 6 |